Chronic nicotine and smoke treatment modulate dopaminergic activities in ventral tegmental area and nucleus accumbens and the γ-aminobutyric acid type B receptor expression of the rat prefrontal cortex

Journal of Neuroscience Research

Volumn 78, Issue 6, 2004, Pages 868-879

  Li, Shu Peng ^a   Park, Moon Seok ^b   Kim, Jong Hun ^a   Kim, Myeong Ok ^a  

^a Gyeongsang National University   (South Korea)

^b Changwon National University   (South Korea)

Author keywords

Cortex; Dopamine receptor; GABAB receptor; Nicotine; Smoke

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; CIGARETTE SMOKE; DOPAMINE 1 RECEPTOR; MESSENGER RNA; NICOTINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERNEURON; MALE; MESENCEPHALON; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PASSIVE SMOKING; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PUTAMEN; RAT; RIBONUCLEASE PROTECTION ASSAY; RNA PROBE; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM; WESTERN BLOTTING;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NICOTINE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-B; RNA, COMPLEMENTARY; SMOKE; TEGMENTUM MESENCEPHALI;

EID: 10644225194     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20329     Document Type: Article

References (71)

1. Abu-Qare AW, Abou-Donia MB. 2001. Quantification of nicotine, chlorpyrifos and their metabolites in rat plasma and urine using high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 757:295-300.
2. B receptor in the nucleus accumbens and the medial prefrontal cortex of the rat after chronic treatment with nicotine. Neurosci Lett 355:161-164.
3. Andersson K, Fuxe K, Agnati LF, Eneroth P. 1981. Effects of acute central and peripheral administration of nicotine on ascending dopamine pathways in the male rat brain. Evidence for nicotine induced increases of dopamine turnover in various telencephalic dopamine nerve terminal systems. Med Biol 59:170-176.
4. Azam L, Winzer-Serhan UH, Chen Y, Leslie FM. 2002. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within mid-brain dopamine neurons. J Comp Neurol 12:260-274.
5. 3H]-D-aspartate and endogenous GABA in freely moving guinea-pigs. Br J Pharmacol 104:15-20.
6. Benke D, Honer M, Michel C, Bettler B, Mohler H. 1999. Gamma-aminobutyric acid type B receptor splice variant proteins GBR1a and GBR1b are both associated with GBR2 in situ and display differential regional and subcellular distribution. J Biol Chem 274:27323-27330.
7. Benwell ME, Balfour DJ. 1992. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br J Pharmacol 105:849-856.
8. Benwell ME, Balfour DJ. 1997. Regional variation in the effects of nicotine on catecholamine overflow in rat brain. Eur J Pharmacol 325:13-20.
9. Bevins RA, Besheer J, Pickett KS. 2001. Nicotine-conditioned locomotor activity in rats: dopaminergic and GABAergic influences on conditioned expression. Pharmacol Biochem Behav 68:135-145.
10. Bianchi C, Ferraro L, Tanganelli S, Morari M, Spalluto G, Simonato M, Beani L. 1995. 5-Hydroxytryptamine-mediated effects of nicotine on endogenous GABA efflux from guinea-pig cortical slices. Br J Pharmacol 116:2724-2728.
11. B receptor. J Biol Chem 279:29085-29091.
12. Carr LA, Rowell PP, Pierce WM Jr. 1989. Effects of subchronic nicotine administration on central dopaminergic mechanisms in the rat. Neurochem Res 14:511-515.
13. Clarke PB, Pert A. 1985. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res 348:355-358.
14. Corrigall WA, Coen KM, Adamson KL. 1994. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653:278-284.
15. Court JA, Lloyd S, Thomas N, Piggott MA, Marshall EF, Morris CM, Lamb H, Perry RH, Johnson M, Perry EK. 1998. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience 87:63-78.
16. Cousins MS, Roberts DC, de Wit H. 2002. GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend 65:209-220.
17. 1 receptor binding in the ventral striatum of cigarette smokers. Synapse 42:48-53.
18. Damsma G, Day J, Fibiger HC. 1989. Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens. Eur J Pharmacol 168:363-368.
19. De Felipe J, Hendry SH, Jones EG, Schmechel D. 1985. Variability in the terminations of GABAergic chandelier cell axons on initial segments of pyramidal cell axons in the monkey sensory-motor cortex. J Comp Neurol 231:364-384.
20. De Schepper PJ, Van Hecken A, Daenens P, Van Rossum JM. 1987. Kinetics of cotinine after oral and intravenous administration to man. Eur J Clin Pharmacol 31:583-588.
21. Doherty MD, Gratton A. 1999. Effects of medial prefrontal cortical injections of GABA receptor agonists and antagonists on the local and nucleus accumbens dopamine responses to stress. Synapse 32:288-300.
22. Donny EC, Caggiula AR, Knopf S, Brown C. 1995. Nicotine self-administration in rats. Psychopharmacology 122:390-394.
23. Du X, Iacovitti L. 1997. Protein kinase C activators work in synergy with specific growth factors to initiate tyrosine hydroxylase expression in striatal neurons in culture. J Neurochem 68:564-569.
24. Ferrari R, Le Novere N, Picciotto MR, Changeux JP, Zoli M. 2002. Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections. Eur J Neurosci 15:1810-1818.
25. Freund TF, Martin KA, Smith AD, Somogyi P. 1983. Glutamate decarboxylase-immunoreactive terminals of Golgi-impregnated axoaxonic cells and of presumed basket cells in synaptic contact with pyramidal neurons of the cat's visual cortex. J Comp Neurol 221:263-278.
26. Galvez T, Duthey B, Kniazeff J, Blahos J, Rovelli G, Bettler B, Prezeau L, Pin JP. 2001. Allosteric interactions between GB1 and GB2 subunits are required for optimal GABA(B) receptor function. EMBO J 20:2152-2159.
27. George TP, Verrico CD, Roth RH. 1998. Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress. Brain Res 801:36-49.
28. George TP, Verrico CD, Picciotto MR, Roth RH. 2000. Nicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterization. J Pharmacol Exp Ther 295:58-66.
29. Glick SD, Visker KE, Maisonneuve IM. 1996. An oral self-administration model of nicotine preference in rats: effects of mecamylamine. Psychopharmacology 128:426-431.
30. Goldman-Rakic PS, Leranth C, Williams SM, Mons N, Geffard M. 1989. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc Natl Acad Sci U S A 86:9015-9019.
31. Grenhoff J, Svensson TH. 1988. Selective stimulation of limbic dopamine activity by nicotine. Acta Physiol Scand 133:595-596.
32. Grenhoff J, Aston-Jones G, Svensson TH. 1986. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 128:351-358.
33. Grobin AC, Deutch AY. 1998. Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat. J Pharmacol Exp Ther 5:350-357.
34. Imperato A, Mulas A, Di Chiara G. 1986. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 132:337-338.
35. Ishiguro H, Ichino N, Yamada K, Nagatsu T. 1997. Nicotine regulates mRNA level of tyrosine hydroxylase gene but not that of nicotinic acetylcholine receptor genes in PC12 cells. Neurosci Lett 228:37-40.
36. Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, Beck P, Mosbacher J, Bischoff S, Kulik A, Shigemoto R, Karschin A, Bettler B. 1998. GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 396:683-687.
37. Kim MO, Li S, Park MS, Hornung JP. 2003. Early fetal expression of GABA(B1) and GABA(B2) receptor mRNAs on the development of the rat central nervous system. Brain Res Dev Brain Res 143:47-55.
38. 2+ signaling and down-regulation of nicotinic acetylcholine receptor subunit expression in the CEM human leukemic T-cell line. Life Sci 72:2155-2158.
39. B receptor functions during formation of alcohol dependence. Alcohol Alcohol Suppl 2:193-197.
40. 2 receptor mRNA levels in the rat substantia nigra. Brain Res 679:157-167.
41. Maggio R, Riva M, Vaglini F, Fornai F, Racagni G, Corsini GU. 1997. Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism. J Neural Transm 104:1113-1123.
42. Mereu G, Yoon KW, Boi V, Gessa GL, Naes L, Westfall TC. 1987. Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur J Pharmacol 141:395-399.
43. Mifsud JC, Hernandez L, Hoebel BG. 1989. Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis. Brain Res 478:365-367.
44. Mitchell SN, Smith KM, Joseph MH, Gray JA. 1993. Increases in tyrosine hydroxylase messenger RNA in the locus coeruleus after a single dose of nicotine are followed by time-dependent increases in enzyme activity and noradrenaline release. Neuroscience 56:989-997.
45. Mukhopadhyay S, Poddar MK. 1995. Caffeine-induced locomotor activity: possible involvement of GABAergic-dopaminergic-adenosinergic interaction. Neurochem Res 20:39-44.
46. 1 receptor occupancy and locomotion produced by intraaccumbens cocaine infusion. Synapse 30:194-204.
47. Nisell M, Nomikos GG, Svensson TH. 1994. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 16:36-44.
48. Nisell M, Nomikos GG, Hertel P, Panagis G, Svensson TH. 1996. Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat. Synapse 22:369-381.
49. Nisell M, Nomikos GG, Chergui K, Grillner P, Svensson TH. 1997. Chronic nicotine enhances basal and nicotine-induced Fos immunoreactivity preferentially in the medial prefrontal cortex of the rat. Neuropsychopharmacology 17:151-161.
50. Ota A, Ichinose H, Kobayashi K, Morita S, Sawada H, Mizuguchi T, Nagatsu T. 1994. Nicotine-induced regulation of tyrosine hydroxylase activity in adrenal gland of transgenic mouse carrying human tyrosine hydroxylase gene. Neurosci Lett 166:55-58.
51. Palmatier MI, Bevins RA. 2002. Examination of GABAergic and dopaminergic compounds in the acquisition of nicotine-conditioned hyperactivity in rats. Neuropsychobiology 45:87-94.
52. Panagis G, Nisell M, Nomikos GG, Chergui K, Svensson TH. 1996. Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat. Brain Res 730:133-142.
53. Parain K, Hapdey C, Rousselet E, Marchand V, Dumery B, Hirsch EC. 2003. Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine parkinsonian toxin. Brain Res 984:224-232.
54. B receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology 172:179-186.
55. Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM, Fuxe K, Changeux JP. 1998. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391:173-177.
56. Rahman S, Zhang J, Corrigall WA. 2003. Effects of acute and chronic nicotine on somatodendritic dopamine release of the rat ventral tegmental area: in vivo microdialysis study. Neurosci Lett 348:61-64.
57. Reavill C, Stolerman IP. 1990. Locomotor activity in rats after administration of nicotinic agonists intracerebrally. Br J Pharmacol 99:273-278.
58. Rotenberg KS, Miller RP, Adir J. 1980. Pharmacokinetics of nicotine in rats after single-cigarette smoke inhalation. J Pharm Sci 69:1087-1090.
59. B receptor agonists and antagonists. Brain Res 630:28-31.
60. Schilstrom B, De Villiers S, Malmerfelt A, Svensson TH, Nomikos GG. 2000. Nicotine-induced Fos expression in the nucleus accumbens and the medial prefrontal cortex of the rat: role of nicotinic and NMDA receptors in the ventral tegmental area. Synapse 36:314-321.
61. Seguela P, Watkins KC, Descarries L. 1988. Ultrastructural features of dopamine axon terminals in the anteromedial and the suprarhinal cortex of adult rat. Brain Res 442:11-22.
62. Sesack SR, Snyder CL, Lewis DA. 1995. Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J Comp Neurol 363:264-280.
63. Shim IS, Won JS, Lee JK, Song DK, Kim SE, Huh SO, Kim YH, Suh HW. 2000. Modulatory effect of ginseng total saponin on dopamine release and tyrosine hydroxylase gene expression induced by nicotine in the rat. J Ethnopharmacol 70:161-169.
64. Smiley JF, Goldman-Rakic PS. 1993. Heterogeneous targets of dopamine synapses in monkey prefrontal cortex demonstrated by serial section electron microscopy: a laminar analysis using the silver-enhanced diaminobenzidine sulfide (SEDS) immunolabeling technique. Cereb Cortex 3:223-238.
65. Sziraki I, Sershen H, Benuck M, Hashim A, Lajtha A. 1998. Receptor systems participating in nicotine-specific effects. Neurochem Int 33:445-457.
66. Sziraki I, Sershen H, Hashim A, Lajtha A. 2002. Receptors in the ventral tegmental area mediating nicotine-induced dopamine release in the nucleus accumbens. Neurochem Res 27:253-261.
67. Tanji J, Hoshi E. 2001. Behavioral planning in the prefrontal cortex. Curr Opin Neurobiol 11:164-170.
68. Van Eden CG, Hoorneman EM, Buijs RM, Matthijssen MA, Geffard M, Uylings HB. 1987. Immunocytochemical localization of dopamine in the prefrontal cortex of the rat at the light and electron microscopical level. Neuroscience 22:849-862.
69. Vezina P, Blanc G, Glowinski J, Tassin JP. 1992. Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections. J Pharmacol Exp Ther 261:484-490.
70. Wolf ME. 1998. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54:679-720.
71. Yeomans J, Baptista M. 1997. Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain-stimulation reward. Pharmacol Biochem Behav 57:915-921.